Neuronetics STIM 深 滬
已收盤 04-02 16:00:00 美东时间
1.52
+0.030
+2.01%
華盛通- 最 高1.54
- 今 開1.43
- 成交量 105.17万股
- 最 低 1.405
- 昨 收 1.49
- 總市值 1.05亿
- 52周最高 4.8495
- 市盈率 靜 --
- 換手率 1.52%
- 52周最低 0.80
- 委 比 -80.39%
- 總股本 6927.66万
- 歷史最高 39.39
- 量 比 0.45
- 振 幅 9.06%
- 歷史最低 0.52
- 每 手 1
- 風險率 1.10%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Jorey Chernett, 10% owner; acquires Neuronetics common shares valued at $210,000
Jorey Chernett, 10% owner; acquires Neuronetics common shares valued at $210,000 Jorey Chernett, a 10% owner of Neuronetics, reported open-market purchases totaling 150,000 common shares. Chernett’s beneficial ownership increased to 8,893,276 common shares following the reported transactions. Discla
03-27 21:37
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
Canaccord Genuity Maintains Buy on Neuronetics, Lowers Price Target to $3
Canaccord Genuity analyst William Plovanic maintains Neuronetics (NASDAQ:STIM) with a Buy and lowers the price target from $7 to $3.
03-20 02:53
Neuronetics 10% owner Jorey Chernett acquires USD 616,000 of common shares
Neuronetics 10% owner Jorey Chernett acquires USD 616,000 of common shares Jorey Chernett, a 10% owner of Neuronetics, reported acquiring 531,000 common shares. The shares were purchased at a weighted average price of USD 1.16 per share. Following the acquisition, Chernett reported beneficial owners
03-18 22:37
Neuronetics Inc. reports Jorey Chernett filed initial beneficial ownership statement
Neuronetics Inc. reports Jorey Chernett filed initial beneficial ownership statement Neuronetics reported that Jorey Chernett filed a Form 3 initial statement of beneficial ownership. The filing lists Chernett as a 10% owner. Chernett reported direct beneficial ownership of 6,985,404 shares of Neuro
03-18 22:32
Neuronetics Appoints New CEO to Lead Next Growth Phase
Neuronetics ( ($STIM) ) has provided an update. On March 12, 2026, Neuronetics’...
03-17 20:42
Neuronetics Sees Q1 Sales $33.000M-$35.000M vs $37.233M Est
Neuronetics (NASDAQ:STIM) sees Q1 sales of $33.000 million-$35.000 million vs $37.233 million analyst estimate.
03-17 19:53
Neuronetics Q4 EPS $(0.10) Beats $(0.11) Estimate, Sales $41.777M Beat $40.667M Estimate
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 6.54 percent. This is a 70.59 percent increase over losses of $(0.34) per share from the
03-17 19:52
BRIEF-Neuronetics Q4 Gross Margin 52%
BRIEF-Neuronetics Q4 Gross Margin 52% Mar 17 (Reuters) - Neuronetics Q4 EPS USD -0.1. Q4 operating expenses USD 26.7 million outlook FY revenue USD 160-166 million outlook Q1 revenue USD 33-35 million
03-17 19:50
